Hodgson Russ Assists UMES In Securing U.S. Patent For Epilepsy Drug

The Hodgson Russ Intellectual Property & Technology Team has successfully assisted the University of Maryland Eastern Shore (UMES) in obtaining a U.S. Patent for a chemical formula treatment for epilepsy. The medical research project that led to this discovery was spearheaded by Dr. Patrice Jackson-Ayotunde, Ph.D., an Associate Professor of Pharmaceutical Sciences at UMES. 65 million people suffer from epilepsy and one in 26 Americans will be diagnosed at some point in their lifetime. Dr. Jackson-Ayotunde focused her research regarding the design and synthesis of novel anticonvulsant analogs as potential agents for treatment of therapy-resistant partial epilepsy. Read the official UMES press release on the patent here: https://www.umes.edu/PR/News-Articles/2018/New-epilepsy-treatment-idea-emerges-at-UMES/